Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00395252
Status:
COMPLETED
Last Update Posted:
2015-10-02
First Post:
2006-11-01
Brief Title:
Safety and Efficacy Therapy of Gemcitabine and Erbitux to R0 or R1 Resected Pancreatic Cancer
Sponsor:
Carmen Schade-Brittinger
Organization:
Philipps University Marburg Medical Center
Organization Data
Organization:
Philipps University Marburg Medical Center
Class:
OTHER
Study ID:
EUDRACT-No 2005-005168-94
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Carmen Schade-Brittinger
Lead Sponsor Class:
OTHER
Responsible Party:
Carmen Schade-Brittinger
Responsible Party Title:
Philipps University
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Philipps University Marburg Medical Center
Old Name:
None
Old Organization:
None